We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Summit Therapeutics Plc | LSE:SUMM | London | Ordinary Share | GB00BN40HZ01 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 20.50 | 18.00 | 23.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
25/1/2018 12:44 | Next month is 7 years since I started investing in Summit & there are many of us who have seen many ups & downs at AGM's etc & much dilutions & now I feel we have at last made it.Well done Summit team & all those on this & the other board who have stuck with Summit.Based on current share price I have now reached past 100% increase in value.Wow. | chrisatrdg | |
25/1/2018 12:42 | I see the NASDAQ to continue trading at 7.30 ET. CONGRATULATIONS EVERYONE! On whatever level ... this is it .... looking forward to a "slap up lunch!" There's no mention of Sarepta in the announcement ... so nothing there just yet! | hugus maximus | |
25/1/2018 12:38 | Wait till the big boys come back from lunch. Only 200k shares traded so far. How many are available? | guss | |
25/1/2018 12:37 | Aim to treat 100% of boys with Utrophin, so market is HUGE. They also have a priority voucher worth $200m which might come into play. Question is might FDA accelerate the approval process alongside the phase 3 placebo trial? | waterloo01 | |
25/1/2018 12:35 | Wow Amazing news Well done WaterlooThis is what you've been waiting for Delighted for all holders and most importantly the patients | tilly99 | |
25/1/2018 12:32 | Any guesses on the value to Summit of this RNS. I assume SRPT bid would only be for part of Summit. AIM pharma shares have gone mad over the last month. | guss | |
25/1/2018 12:25 | In some shock as to be honest, I thought it wouldn't be quite so good as it seems. Most recent broker was at $80 (closed at $12), and most of that based on C.diff. SRPT bound to make a bid IMO. What price! | waterloo01 | |
25/1/2018 12:15 | RNS not showing up on a few data providers for some reason. I took advantage ;) | phowdo | |
25/1/2018 12:14 | My thoughts too waterloo01 below as posted on the other board earlier this morning: 'RNS - Wow Oh my goodness Summit have fooled us all & I am amazed that the report is out before the end of the first month this quarter. Well done Summit now lets see how AIM reacts.' | chrisatrdg | |
25/1/2018 12:13 | Wow!!! Aim should move more than it has currently. | clarkey26 | |
25/1/2018 12:09 | Wow. It works. | waterloo01 | |
25/1/2018 12:08 | Price jumped this AM. DMD results? SRPT take over DMD? Should find out soon. Just in time for a slap up lunch!! | waterloo01 | |
25/1/2018 12:05 | What's up .... SUMMIT HALTED ON NASDAQ PENDING NEWS ... ? | hugus maximus | |
24/1/2018 16:57 | Very Interesting, thanks Waterloo. | algernon2 | |
22/1/2018 20:18 | My reply: Hi Davielad - Thanks for the post SRPT is currently up 5.31% $65.69 which would be if no change a 52 wk high which seems to support your posting.Currently SMMT is up 5.26% $12.81 = £1.84.Will be interesting if this trend does not change how the share price will react on AIM this Tuesday. | chrisatrdg | |
22/1/2018 20:18 | Per Davielad this evening from the other board: 'Just watched CNBC power Lunch..... Interesting piece on prospective M&A activity in the Biotech Sector. Specifically speculation that Biogen has SRPT as a potential target. ...... And of strong M&A activity in the sector generally. This may account for the rise just now on the NASDAQ. I think the whole sector is up today' | chrisatrdg | |
22/1/2018 16:15 | Premarket analyst action - healthcare (includes Serepta): | chrisatrdg | |
18/1/2018 21:17 | Hi waterloo. On another board, someone suggested that institutional buyers almost always get the mid price or thereabouts, despite the size of their order. No idea how true this is as I don't pretend to understand trades. If they are right, it suggests they could be II buys. I'd like to think so. Pity nasdaq lost upward momentum later on. | luminoso | |
18/1/2018 18:19 | We are the Invincibles, and we are here to serve you better, we are pro in all form of hacks and available for hire, we help in securing company websites, hack any form of social media, we are available for any special project but all hack must come with a reasonable proposal as we don't just accept any hack without a legit or legal reason. You can reach our website to read more and hire us. We are invincibles, we keep our words. | invincibles | |
18/1/2018 18:07 | Nasdaq up so maybe they are buys. | waterloo01 | |
18/1/2018 16:35 | Two very large trades 133k followed by 118k. price 1.78 & 1.77 so not clear a work buy or sell. | waterloo01 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions